Overview
invoX Pharma develops innovative and generic drug-device combination products using a proprietary next-generation soft mist inhaler platform called Softhaler®. The company maintains a flexible supply chain offering development through commercial supply services, and has a diversified pipeline of clinical and pre-clinical stage respiratory drug candidates.
Leadership & org chart
In the news
- We're hiring! We're looking for a Senior Project Manager to join our PMO team. This is a permanent, hybrid/flexible role that will require to you to proactively monitor progress, manage risk, drive stakeholder alignment, and foster strong internal and external relationships. Find out more and apply via the link below. https://lnkd.in/ebDKu56c
- A fantastic week for invoX at the #BIOInternational Convention, and a thank you to everyone who took the time to connect with us. This year's theme was "Driven by Purpose", a fitting reflection of the biotech industry’s persistence for solving the impossible. Here at invoX, we reflect this theme by consistently pushing the boundaries of what can be achieved within the drug delivery space. Our proprietary soft mist inhaler platform, Softhaler®, was developed to deliver the next generation of inhaled therapeutics. As the
- The 2026 #BIOInternational Convention is underway in San Diego. invoX is here to connect with partners exploring the next generation of inhaled medicine. The Softhaler®, our proprietary soft mist inhaler platform, delivers a broad range of therapies, from small molecules to complex biologics, directly to the lung. Interested in how invoX and the Softhaler® can support the advancement of your pipeline? William Ward is representing invoX throughout the convention. Connect with him via the delegate tab on the BIO Partnering™
- Less than a week until #BIOInternational 2026! Whether you're working with small molecules or biologics, developing novel inhaled therapies, or looking to get more from your existing pipeline - The Softhaler®, our next-generation soft mist inhaler, is ready to support. Here's where to find us in San Diego (and beyond): 1) BIO Partnering™ platform: search "invoX Pharma" or find William Ward's delegate profile. 2) LinkedIn: message us directly for partnership opportunities or any other enquiries. 3) Our partnership page:
- We are pleased to share that our Head of Research Danny Brinkley attended this year’s SMI London conference on behalf of invoX last week. A strong theme shared amongst presenters this year involved the rapid evolution of soft mist inhalers (SMIs) towards the delivery of complex biologics and advanced therapeutics. Here at invoX, we strongly reflect this shared sentiment. Our internal research and external collaborations already focus on next-generation complex medicines, including biologics and other advanced therapies. It is
Something wrong or missing? Send an update. Fixed within 24 hours.